InvestorsHub Logo
Followers 3157
Posts 961354
Boards Moderated 204
Alias Born 09/04/2000

Re: Ablivious post# 528

Wednesday, 08/05/2020 10:39:45 AM

Wednesday, August 05, 2020 10:39:45 AM

Post# of 552
$AKTX Akari Therapeutics PLC (NASDAQ: AKTX): interim update on the Part B placebo-controlled efficacy arm of the study of nomacopan eye drops in atopic keratoconjunctivitis
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AKTX News